ACTIVITY OF CYTOSTATIC DRUGS IN 2 HETEROTRANSPLANTED HUMAN TESTICULAR CANCER CELL-LINES WITH DIFFERENT SENSITIVITY TO STANDARD AGENTS

被引:11
|
作者
HARSTRICK, A
SCHMOLL, HJ
CASPER, J
WILKE, H
POLIWODA, H
机构
[1] Department of Hematology and Oncology, University of Hannover Medical School, 3000 Hannover 61
关键词
D O I
10.1016/0277-5379(90)90195-Y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two established human testicular cancer cell lines were used in a mouse xenograft model to assess the antitumour activity of 15 anticancer agents. Line H 12.1 was highly sensitive to cisplatin, bleomycin and vinblastine, resembling non-pretreated testicular tumours, whereas line H 23.1 showed resistance to cisplatin and vinblastine, comparable to tumours with acquired or intrinsic drug resistance. In line H 12.1 several drugs were highly active, including cyclophosphamide, ifosfamide, nimustine and vincristine; carmustine, vindesine, doxorubicin, epidoxorubicin, pirarubicin, mitoxantrone, carboplatin and iproplatin had only moderate activity. In line H 23.1 only cyclophosphamide, ifosfamide, nimustine, vincristine and bleomycin had antitumour activity. These two cell lines represent a useful model for preclinical evaluation of new agents with presumed activity in testis cancer. © 1990.
引用
收藏
页码:898 / 901
页数:4
相关论文
共 50 条
  • [31] ESTABLISHMENT OF 6 HUMAN PANCREATIC-CANCER CELL-LINES AND THEIR SENSITIVITIES TO ANTITUMOR DRUGS
    KOBARI, M
    HISANO, H
    MATSUNO, S
    SATO, T
    KAN, M
    TACHIBANA, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 150 (03): : 231 - 248
  • [32] COMPARISON OF THE ANTITUMOR-ACTIVITY OF CISPLATIN, CARBOPLATIN, AND IPROPLATIN AGAINST ESTABLISHED HUMAN TESTICULAR CANCER CELL-LINES INVIVO AND INVITRO
    HARSTRICK, A
    CASPER, J
    GUBA, R
    WILKE, H
    POLIWODA, H
    SCHMOLL, HJ
    CANCER, 1989, 63 (06) : 1079 - 1083
  • [33] DIFFERENTIAL SENSITIVITY OF HUMAN CANCER CELL-LINES TO PROTEIN-KINASE-C AGONISTS
    MENENDEZ, AT
    KOZIKOWSKI, A
    DOUGHERTY, M
    KRAMER, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 91 - 91
  • [34] ANTIPROLIFERATIVE ACTIVITY OF HALOOSMOCENIUM IONS AGAINST HUMAN AND MURINE CANCER CELL-LINES
    YAMAZAKI, Y
    GOTO, M
    KOBAYASHI, K
    OGAWA, Y
    SHIMURA, T
    OKA, S
    OKUNO, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (03) : 483 - 486
  • [35] Cytostatic Activity of Clinoptilolite against Human Cervical Cancer Cell Lines using Three Different Media-Sterilization Techniques
    Ghazi, Noor Azhana
    Malek, Nik Ahmad Nizam Nik
    Hamdan, Salehhuddin
    ADVANCED MATERIALS ENGINEERING AND TECHNOLOGY, 2012, 626 : 667 - +
  • [36] Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
    Buzharevski, Antonio
    Paskas, Svetlana
    Laube, Markus
    Loesnnecke, Peter
    Neumann, Wilma
    Murganic, Blagoje
    Mijatovic, Sanja
    Maksimovic-Ivanic, Danijela
    Pietzsch, Jens
    Hey-Hawkins, Evamarie
    ACS OMEGA, 2019, 4 (05): : 8824 - 8833
  • [37] COMPARATIVE EFFECTS OF TAXOL AND TAXOTERE ON 2 DIFFERENT HUMAN CARCINOMA CELL-LINES
    GARCIA, P
    BRAGUER, D
    CARLES, G
    ELKHYARI, S
    BARRA, Y
    DEINES, C
    BARASOAIN, I
    BRIAND, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (04) : 335 - 343
  • [38] DETERMINATION OF 8 ELEMENTS IN 6 HUMAN CANCER CELL-LINES AND 2 HUMAN NORMAL-CELL LINES BY PIXE
    TONG, YP
    ZHANG, YP
    XU, YL
    RUI, JY
    LI, MQ
    SHEN, CY
    XIAO, ZM
    HONG, JX
    BIOLOGICAL TRACE ELEMENT RESEARCH, 1991, 29 (01) : 31 - 34
  • [39] RADIATION SENSITIVITY AND STUDY OF GLUTATHIONE AND RELATED ENZYMES IN HUMAN COLORECTAL-CANCER CELL-LINES
    CARMICHAEL, J
    PARK, JG
    DEGRAFF, WG
    GAMSON, J
    GAZDAR, AF
    MITCHELL, JB
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (07): : 1219 - 1224
  • [40] THE EFFECT OF CYTOTOXIC DRUGS ON THE ESTROGEN-RECEPTOR STATUS OF 2 HUMAN-BREAST CANCER CELL-LINES INVITRO
    CLARKE, R
    MOORWOOD, J
    VANDENBERG, HW
    NELSON, J
    MURPHY, RF
    IRISH JOURNAL OF MEDICAL SCIENCE, 1986, 155 (05) : 172 - 173